5 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A 6-Month MDR-END Plus Regimen for Rifampicin-Resistant TuberculosisActinomycetales infectious disease, Bacterial Infections and Mycoses, Infections, bacterial infectious disease, gram-positive bacterial infections, multidrug-resistant tuberculosis, mycobacterial infectious disease, rifampicin-resistant tuberculosis, tuberculosisNot yet recruitingPhase 32026-06-30NCT07675954
Acetohydroxamic Acid Combined With a Short-Course Regimen for MDR-TB (AHA-PLUS)Actinomycetales infectious disease, Bacterial Infections and Mycoses, Infections, bacterial infectious disease, gram-positive bacterial infections, multidrug-resistant tuberculosis, mycobacterial infectious disease, rifampicin-resistant tuberculosis, tuberculosisNot yet recruitingPhase 22026-02-06NCT07393438
A Phase 2b Clinical Study of JDB0131 Benzenesulfonate TabletsActinomycetales infectious disease, Bacterial Infections and Mycoses, Infections, bacterial infectious disease, gram-positive bacterial infections, mycobacterial infectious disease, rifampicin-resistant tuberculosis, tuberculosisRecruitingPhase 22026-01-30NCT07170800
Innovating Shorter, All- Oral, Precised, Individualized Treatment Regimen for Rifampicin Resistant Tuberculosis:Contezolid, Delamanid and Bedaquiline CohortActinomycetales infectious disease, Bacterial Infections and Mycoses, Infections, bacterial infectious disease, gram-positive bacterial infections, lung disorder, mycobacterial infectious disease, pulmonary tuberculosis, respiratory system disorder, respiratory tract infectious disorder, rifampicin-resistant tuberculosis, tuberculosisActive, not recruitingPhase 32025-04-01NCT06081361
French National Cohort of Patients With Rifampicin-Resistant TuberculosisActinomycetales infectious disease, Bacterial Infections and Mycoses, Infections, bacterial infectious disease, gram-positive bacterial infections, mycobacterial infectious disease, rifampicin-resistant tuberculosis, tuberculosisNot yet recruitingNot stated2024-08-22NCT06565806